Further, mutations in DNA methyltransferase 3 alpha (DNMT3A) and tumor protein 53 (TP53) genes, which drive AML in adult patients, were absent in nearly all pediatric AML cases analyzed [9,10,11]. The gene discussed is TP53; the disease is acute myeloid leukemia.